Doctors from Scotland and the US have completed what is thought to be a world-first stroke procedure using a robot. BBC News ...
A Vero Beach woman is getting her independence back after a stroke, thanks to a cutting-edge device now being used at ...
The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be ...
Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug ...
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...
CHRISTUS Health is expanding neurological care to treat strokes and aneurysms in San Antonio's Westover Hills community.
OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...
The results have potential to change clinical practice.NEW ORLEANS — Left atrial appendage closure in patients with atrial ...
Substantial reductions in adverse cardiovascular outcomes are especially notable for this high-risk population, but ...
For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications may not be sufficient in helping them reach their target cholesterol levels.
In patients with atherosclerosis and/or diabetes without a prior heart attack or stroke, evolocumab cut the risk for first ...
It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback